| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2006;37:466.)
© 2006 American Heart Association, Inc.
Original Contributions |
From the Department of Neurology (H.-M.K., B.J.K., S.-H.L., B.-W.Y.), Seoul National University Hospital, Korea; and Healthcare Research Institute (S.H.C., B.-H.O.), Seoul National University Hospital Healthcare System Gangnam Center, Korea.
Correspondence to Byung-Woo Yoon, MD, PhD, Department of Neurology, Seoul National University Hospital, Yongon-dong 28, Chongno-gu, Seoul 110-744, Republic of Korea. E-mail bwyoon{at}snu.ac.kr
Background and Purpose Metabolic syndrome (MetS) is associated with an increased risk of the subsequent development of cardiovascular disease or stroke. Moreover, a silent brain infarction (SBI) can predict clinical overt stroke or dementia. We examined the associations between SBI and MetS in apparently healthy individuals.
Methods We evaluated 1588 neurologically healthy subjects (927 males and 661 females) who underwent brain MRI at Seoul National University Hospital Healthcare System Gangnam Center. MetS was defined using the criteria of the National Cholesterol Education Program Adult Treatment Panel III. We examined associations between full syndrome (
3 of the 5 conditions) as well as its components and SBI by controlling possible confounders.
Results Eighty-eight (5.5%) were found to have
1 SBI on MRI. Age was found to be significantly related to SBI prevalence (odds ratio [OR], 1.06; 95% CI, 1.04 to 1.09). A history of coronary artery disease was associated with an elevated odds ratio of SBI (OR, 2.83; 95% CI, 1.38 to 5.82), and MetS was significantly associated with SBI (OR, 2.18; 95% CI, 1.38 to 3.44). The components model of MetS showed a strong significance between an elevated blood pressure (OR, 3.75; 95% CI, 2.05 to 6.85) and an impaired fasting glucose (OR, 1.74; 95% CI, 1.08 to 2.80) and the risk of SBI.
Conclusions MetS was found to be significantly associated with SBI. This finding has clinical utility in terms of identifying healthy people at increased risk of developing SBI.
Key Words: cerebral infarction magnetic resonance imaging metabolic syndrome x risk factors
This article has been cited by other articles:
![]() |
K Park, N Yasuda, S Toyonaga, E Tsubosaki, H Nakabayashi, and K Shimizu Significant associations of metabolic syndrome and its components with silent lacunar infarction in middle aged subjects J. Neurol. Neurosurg. Psychiatry, June 1, 2008; 79(6): 719 - 721. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Bokura, S. Yamaguchi, K. Iijima, A. Nagai, and H. Oguro Metabolic Syndrome Is Associated With Silent Ischemic Brain Lesions Stroke, May 1, 2008; 39(5): 1607 - 1609. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Park, N. Yasuda, S. Toyonaga, S. M. Yamada, H. Nakabayashi, M. Nakasato, T. Nakagomi, E. Tsubosaki, and K. Shimizu Significant association between leukoaraiosis and metabolic syndrome in healthy subjects Neurology, September 4, 2007; 69(10): 974 - 978. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. V. Bowler and P. B. Gorelick Advances in Vascular Cognitive Impairment 2006 Stroke, February 1, 2007; 38(2): 241 - 244. [Full Text] [PDF] |
||||
![]() |
Metabolic Syndrome and Stroke Risk Journal Watch Neurology, May 4, 2006; 2006(504): 1 - 1. [Full Text] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2006 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |